Core Viewpoint - The financial performance of Purui Eye Hospital Group shows mixed results, with a slight increase in revenue but a significant decrease in net profit, indicating potential challenges in profitability despite stable revenue growth [2][3]. Group 1: Financial Performance - As of June 30, 2025, Purui Eye Hospital achieved a revenue of 1.459 billion yuan, representing a year-on-year growth of 2.74% [2]. - The net profit attributable to shareholders for the same period was 14.67 million yuan, reflecting a substantial decline of 66.12% compared to the previous year [2]. - Cumulative cash dividends distributed since the company's A-share listing amount to 74.51 million yuan [3]. Group 2: Shareholder and Market Activity - As of August 28, 2023, the total number of shareholders for Purui Eye Hospital reached 10,600, an increase of 6.24% from the previous period [2]. - The average number of circulating shares per shareholder is 6,647, which is a decrease of 5.87% from the previous period [2]. - On August 28, 2023, the financing balance for Purui Eye Hospital was 94.61 million yuan, accounting for 1.47% of its market capitalization, indicating a low financing level compared to the past year [1]. Group 3: Institutional Holdings - As of June 30, 2025, the third-largest circulating shareholder is Rongtong Health Industry Flexible Allocation Mixed A/B, holding 2.5925 million shares, an increase of 692,400 shares from the previous period [3]. - Yuanxin Yongfeng Ju You A is a new entrant among the top ten circulating shareholders, holding 1.7668 million shares [3]. - The tenth-largest circulating shareholder, ICBC Medical Care Stock, reduced its holdings by 90,000 shares compared to the previous period [3].
普瑞眼科8月28日获融资买入1640.88万元，融资余额9407.71万元